Croda International Plc (LON:CRDA – Get Free Report) shares passed above its two hundred day moving average during trading on Friday after JPMorgan Chase & Co. upgraded the stock to an overweight rating. The stock has a two hundred day moving average of GBX 2,826.57 ($38.10) and traded as high as GBX 2,877 ($38.78). Croda International shares last traded at GBX 2,871 ($38.70), with a volume of 1,014,705 shares trading hands.
Several other brokerages have also issued reports on CRDA. Citigroup lowered their target price on Croda International from GBX 3,550 to GBX 3,300 and set a “neutral” rating on the stock in a research note on Tuesday, April 29th. Berenberg Bank reiterated a “buy” rating and issued a GBX 3,800 price target on shares of Croda International in a research report on Thursday, April 24th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 3,087.50.
Check Out Our Latest Stock Analysis on CRDA
Insider Buying and Selling
Croda International Stock Performance
The company has a 50-day moving average of GBX 2,584.83 and a 200 day moving average of GBX 2,826.57. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. The firm has a market capitalization of £4.01 billion, a PE ratio of 1,864.29, a PEG ratio of 1.40 and a beta of 0.74.
Croda International (LON:CRDA – Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported GBX 72.20 earnings per share (EPS) for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. Equities research analysts predict that Croda International Plc will post 181.8307268 EPS for the current year.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Recommended Stories
- Five stocks we like better than Croda International
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Retail Stocks Investing, Explained
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.